Big pharma competes bitterly with the tech giants for the title of most dodgy corporate sector in the world. Given this ...

Respiratory syncytial virus (RSV) causes severe illness in millions of young children each year.1 Globally, it is estimated that over 100 000 children younger than 5 years die each year from RSV; 97% ...

Brings 20+ years of revenue growth leadership in laboratory testing, clinical diagnostics and global expansionLed successful organizational turnarounds and growth strategies at both Boston Heart Diagn ...

Prokaryotics Inc., a privately-held biopharmaceutical company engaged in the discovery and development of novel anti-infective drugs, announced today that it has entered into a licensing agreement ...

Germany’s Formycon announced that Klinge Biopharma, the exclusive owner of the global commercialization rights of ...

Historic changes are afoot for pharma as China gains ground on U.S. production. The pharma industry is projected to see ...

Research presented at the ASCO Annual Meeting 2025 highlighted potential new standards of care and other advances in ...

Gender inequalities continue to pose significant barriers to health, limiting access to essential services and increasing health risks for women and girls. Addressing these inequalities is not just a ...

Colorectal cancer highlights from ASCO 2025 include findings from the BREAKWATER, ATOMIC, DYNAMIC-III, and TRIPLETE trials.

NORTHAMPTON, MA / ACCESS Newswire / June 24, 2025 / Despite widely publicized efforts by the Trump administration and certain Republican-led state governments ...